Last year, the company's early-stage breast cancer detection test became the first such test to receive the Breakthrough Device Designation
CliniSys has the proven ability to deliver 100s of millions of medical results a month to enable pandemic-scale population disease surveillance across the globe
Effectiveness of Covaxin against the Omicron variant is currently being studied
Lupin Diagnostics will provide a comprehensive range of diagnostic tests. These include molecular diagnostics, cytogenetics, flow cytometry, microbiology, serology, histopathology and cytology, haematology, immunology, amongst others.
It is the first blood test able to detect early-stage Breast Cancer with high accuracy in women above the age of 40 years
LSDCheck is CE-IVD approved LCMSMS-based testing kit for LSD in newborns
The rolling submission to the U.S. FDA will begin in the fourth quarter of this year
Takeda to exclusively commercialize JR-141 outside the U.S. (except Japan and certain other Asia-Pacific countries) upon regulatory approval
The NanoDrop Eight simultaneously evaluates eight samples in 20 seconds or less and the instrument can also measure high-concentration samples of up to 200 absorbance units without dilution
The study is being carried out by the platform VISION (Vaccine Immunology Studies – Indian Outbreak-response Network) which includes top public and private research institutes.
Subscribe To Our Newsletter & Stay Updated
